Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Coagulation factors directly cleave SARS-CoV-2 spike and enhance viral entry
Edward R. Kastenhuber, Marisa Mercadante, Benjamin E. Nilsson-Payant, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 55

Showing 1-25 of 55 citing articles:

Long COVID: mechanisms, risk factors and recovery
Rónan Astin, Amitava Banerjee, Mark R. Baker, et al.
Experimental Physiology (2022) Vol. 108, Iss. 1, pp. 12-27
Open Access | Times Cited: 170
Mucosal immune responses to infection and vaccination in the respiratory tract
Robert C. Mettelman, E. Kaitlynn Allen, Paul G. Thomas
Immunity (2022) Vol. 55, Iss. 5, pp. 749-780
Open Access | Times Cited: 155
ACE2-Independent Interaction of SARS-CoV-2 Spike Protein with Human Epithelial Cells Is Inhibited by Unfractionated Heparin
Lynda J. Partridge, Lucy Urwin, Martin J. H. Nicklin, et al.
Cells (2021) Vol. 10, Iss. 6, pp. 1419-1419
Open Access | Times Cited: 63
The potential role of ischaemia–reperfusion injury in chronic, relapsing diseases such as rheumatoid arthritis, Long COVID, and ME/CFS: evidence, mechanisms, and therapeutic implications
Douglas B. Kell, Etheresia Pretorius
Biochemical Journal (2022) Vol. 479, Iss. 16, pp. 1653-1708
Open Access | Times Cited: 52
Dimethyl fumarate and 4-octyl itaconate are anticoagulants that suppress Tissue Factor in macrophages via inhibition of Type I Interferon
Tristram A.J. Ryan, Alexander Hooftman, Aisling M. Rehill, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 37
Coagulation Disorders in Sepsis and COVID-19—Two Sides of the Same Coin? A Review of Inflammation–Coagulation Crosstalk in Bacterial Sepsis and COVID-19
Georgeana Tuculeanu, Ecaterina Constanța Barbu, Mihai Lazăr, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 2, pp. 601-601
Open Access | Times Cited: 23
Development of ketobenzothiazole-based peptidomimetic TMPRSS13 inhibitors with low nanomolar potency
Alexandre Joushomme, Antoine Désilets, William Champagne, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2025) Vol. 40, Iss. 1
Open Access | Times Cited: 1
Aged brain and neuroimmune responses to COVID-19: post-acute sequelae and modulatory effects of behavioral and nutritional interventions
Ludmila Müller, Svetlana Di Benedetto
Immunity & Ageing (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 22
Initial immune response after exposure to Mycobacterium tuberculosis or to SARS-COV-2: similarities and differences
Alessandra Aiello, Saeid Najafi Fard, Delia Goletti
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 22
COVID-19 Convalescent Plasma Is More than Neutralizing Antibodies: A Narrative Review of Potential Beneficial and Detrimental Co-Factors
Daniele Focosi, Massimo Franchini, Liise‐anne Pirofski, et al.
Viruses (2021) Vol. 13, Iss. 8, pp. 1594-1594
Open Access | Times Cited: 40
Anti-prothrombin autoantibodies enriched after infection with SARS-CoV-2 and influenced by strength of antibody response against SARS-CoV-2 proteins
Marc Emmenegger, Sreedhar Saseendran Kumar, Vishalini Emmenegger, et al.
PLoS Pathogens (2021) Vol. 17, Iss. 12, pp. e1010118-e1010118
Open Access | Times Cited: 39
Accelerating discovery: A novel flow cytometric method for detecting fibrin(ogen) amyloid microclots using long COVID as a model
Simone Turner, Gert Jacobus Laubscher, Asad Khan, et al.
Heliyon (2023) Vol. 9, Iss. 9, pp. e19605-e19605
Open Access | Times Cited: 13
An Emerging Role for Type I Interferons as Critical Regulators of Blood Coagulation
Tristram A.J. Ryan, Luke O'neill
Cells (2023) Vol. 12, Iss. 5, pp. 778-778
Open Access | Times Cited: 11
Risk Factors for Long COVID in Older Adults
Yunguang Hu, Yifan Liu, Huiwen Zheng, et al.
Biomedicines (2023) Vol. 11, Iss. 11, pp. 3002-3002
Open Access | Times Cited: 11
Structural and functional properties of the SARS-CoV-2 spike protein: Potential vaccine and drug development for COVID-19
Reed L. Berkowitz, David A. Ostrov
Elsevier eBooks (2025), pp. 57-74
Closed Access
Unravelling the impact of SARS-CoV-2 on hemostatic and complement systems: a systems immunology perspective
Didar Murad, Rehan Zafar Paracha, Maryum Nisar
Frontiers in Immunology (2025) Vol. 15
Open Access
GGCX promotes Eurasian avian-like H1N1 swine influenza virus adaption to interspecies receptor binding
Jiahui Zou, Meijun Jiang, Rong Xiao, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Inhaled heparin polysaccharide nanodecoy against SARS-CoV-2 and variants
Bin Tu, Huiyuan Wang, Xinran An, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 7, pp. 3187-3194
Open Access | Times Cited: 17
Genome-wide bioinformatics analysis of human protease capacity for proteolytic cleavage of the SARS-CoV-2 spike glycoprotein
Э. В. Матвеев, Gennady V. Ponomarev, Marat D. Kazanov
Microbiology Spectrum (2024) Vol. 12, Iss. 2
Open Access | Times Cited: 3
Safety and Efficacy of Camostat Mesylate for Covid-19: a systematic review and Meta-analysis of Randomized controlled trials
Ubaid Khan, Muhammad Mubariz, Yehya Khlidj, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
COVID‐19 coagulopathies: Human blood proteins mimic SARS‐CoV‐2 virus, vaccine proteins and bacterial co‐infections inducing autoimmunity
Robert Root‐Bernstein
BioEssays (2021) Vol. 43, Iss. 12
Open Access | Times Cited: 21
SARS-CoV-2 Spike-Mediated Entry and Its Regulation by Host Innate Immunity
Yu Shi, Huina Hu, Qiangyun Ai, et al.
Viruses (2023) Vol. 15, Iss. 3, pp. 639-639
Open Access | Times Cited: 9
Omicsynin B4 potently blocks coronavirus infection by inhibiting host proteases cathepsin L and TMPRSS2
Yihua Li, Kun Wang, Hongmin Sun, et al.
Antiviral Research (2023) Vol. 214, pp. 105606-105606
Open Access | Times Cited: 8
Synergistic inhibition of SARS-CoV-2 cell entry by otamixaban and covalent protease inhibitors: pre-clinical assessment of pharmacological and molecular properties
Tim Hempel, Katarina Elez, Nadine Krüger, et al.
Chemical Science (2021) Vol. 12, Iss. 38, pp. 12600-12609
Open Access | Times Cited: 19
The Spike-Stabilizing D614G Mutation Interacts with S1/S2 Cleavage Site Mutations To Promote the Infectious Potential of SARS-CoV-2 Variants
Stacy Gellenoncourt, Nell Saunders, Rémy Robinot, et al.
Journal of Virology (2022) Vol. 96, Iss. 19
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top